Skip to main content
Erschienen in: BMC Cardiovascular Disorders 1/2019

Open Access 01.12.2019 | Case report

Another Whipple’s triad? Pericardial, myocardial and valvular disease in an unusual case presentation from a Canadian perspective

verfasst von: Christina S. Thornton, Yinong Wang, Martin Köebel, Kathryn Bernard, Tamara Burdz, Andrew Maitland, Jose G. Ferraz, Paul L. Beck, Andre Ferland

Erschienen in: BMC Cardiovascular Disorders | Ausgabe 1/2019

Abstract

Background

Whipple’s disease is a clinically relevant multi-system disorder that is often undiagnosed given its elusive nature. We present an atypical case of Whipple’s disease involving pan-valvular endocarditis and constrictive pericarditis, requiring cardiac intervention. A literature review was also performed assessing the prevalence of atypical cases of Whipple’s disease.

Case presentation

A previously healthy 56-year-old male presented with a four-year history of congestive heart failure with weight loss and fatigue. Notably, he had absent gastrointestinal symptoms. He went on to develop pan-valvular endocarditis and constrictive pericarditis requiring urgent cardiac surgery. A clinical diagnosis of Whipple’s disease was suspected, prompting duodenal biopsy sampling which was unremarkable, Subsequently, Tropheryma whipplei was identified by 16S rDNA PCR on the cardiac valvular tissue. He underwent prolonged antibiotic therapy with recovery of symptoms.

Conclusions

Our study reports the first known case of Whipple’s disease involving pan-valvular endocarditis and constrictive pericarditis. A literature review also highlights this presentation of atypical Whipple’s with limited gastrointestinal manifestations. Duodenal involvement was limited and the gold standard of biopsy was not contributory. We also highlight the Canadian epidemiology of the disease from 2012 to 2016 with an approximate 4% prevalence rate amongst submitted samples. Routine investigations for Whipple’s disease, including duodenal biopsy, in this case may have missed the diagnosis. A high degree of suspicion was critical for diagnosis of unusual manifestations of Whipple’s disease.

Background

Whipple’s disease is a rare disease that classically afflicts middle-aged white men with an annual incidence of > 1/1,000,000. The prototypical clinical presentation of Whipple’s includes arthralgia (87%), diarrhea (81%), weight loss (93%), lymphadenopathy (52%), neurologic symptoms (33%), fever (38%) and melanoderma (41%), but with 15% of individuals lacking these classics symptoms [13].
Cardiac manifestations involving Whipple’s disease are atypical but are often described as endocarditis, considered the most useful clinical finding [3, 4]. Several of the case reports involving endocarditis have a geographic predominance from France [5] to southern Germany [6]. It has been speculated that prevalence of T. whipplei is higher in these so-thought ‘endemic’ areas or perhaps clinical suspicion of Whipple’s is greater. As the bacterium is ubiquitous within the soil environment, there has been speculation of an oral infectious route [4]. Amongst healthy individuals, T. whipplei has been found in 1–11% of stool samples, and up to 26% of sewage plant workers [7]. Pericardial involvement, namely constriction, is a rare clinical finding in patients with Whipple’s disease. To our knowledge, this is the first report of confirmed Whipple’s disease with constrictive pericarditis in concordance with multi-valvular pancarditis.

Case presentation

A 56-year-old Caucasian male presented with a diagnosis of recurrent heart failure. Previously, he was given a diagnosis of palindromic rheumatism based on a four-year history of lower extremity migratory joint pain and swelling that failed to respond to NSAIDs and hydroxychloroquine. During this time, he also developed unintentional weight loss, fatigue and cognitive impairment. Past medical history was significant for a renal cell carcinoma, treated with a left nephrectomy 4 years prior to presentation. The patient had a 45-pack year smoking history. He had not travelled abroad except for New Zealand and Hawaii 25 years ago.
The patient had been previously evaluated over 4 years by numerous services including rheumatology, hematology, cardiology and dermatology with an extensive work-up, including blood cultures that were negative on repeat occasions (Table 1). Eleven months prior to current presentation, the patient developed recurrent acute congestive heart failure exacerbation, requiring multiple admissions with treatment involving diuretics and chest tubes, providing limited short-term symptomatic relief.
Table 1
Results of Work-up Preceding Hospital Admission
Test (Units)
Results from Work-up (Reference Range)a
Hemoglobin (g/L)
80 (137–180)
Mean corpuscular volume (fL)
84 (82–100)
Platelets (109/L)
215 (150–400)
Leukocyte Count (109/L)
4.9 (4–11)
Absolute Neutrophil Count (109/L)
3.8 (2–8)
Creatinine (umol/L)
88 (50–120)
Aspartate aminotransferase (U/L)
48 (8–40)
Alanine aminotransferase (U/L)
66 (1–60)
Bilirubin total (umol/L)
18 (0–24)
Complement, C3 (g/L)
0.8 (0.6–1.6)
Complement, C4 (g/L)
0.2 (0.1–0.4)
HIV
Negative
Brucella
Negative
Tularensis
Negative
Yersina
Negative
Toxoplasmosis
Negative
Bartonella
Negative
Syphilis
Negative
Cytomegalovirus
Negative
Hepatitis B
Negative
Hepatitis C
Negative
Epstein-Barr virus
Negative
Mycobacterium tuberculosis
Negative
IgG4
Negative
Extractable nucleic antigen
Negative
Neutrophil cytoplasmic antibodies
Negative
Rheumatoid factor
Negative
Anti-cyclic citrullinated peptide antibody (U/mL)
795 (< 5)
Serum protein electrophoresis
Normal
AM cortisol (nmol/L)
491 (170–500)
C-reactive peptide (mg/L)
72 (0–8)
CT Scan
Numerous non-specific lymphadenopathy. A PET CT scan showed diffuse bilateral axillary, inguinal, mediastinum, abdominal and pelvic lymphadenopathy with no FDG uptake
Bone marrow biopsy
Minimal monoclonal B cells
Axillary lymph node biopsy
Inflammation with non-caseating clusters of various cell types with reactive follicular hyperplasia with some features of dermatopathic lymphadenitis and focal granuloma formation
Skin biopsy
Melanoderma
Transthoracic Echocardiogram
Mild reduction in left ventricular systolic function with hypokinesis to the inferior basal and mid-segments. Mild right ventricle systolic dysfunction was noted with moderate pulmonary hypertension (RSVP 55 mmHg). No evidence of constrictive pericardium and no significant valvular disease
aWhere applicable
On this presentation, the patient had symptoms consistent with an exacerbation of congestive heart failure. The patient stated he had lost approximately 40 pounds over 6 months. He denied any GI symptoms, fevers, chills or night sweats. Physical examination revealed the patient as pale, afebrile and hemodynamically stable. He was noted to be cachectic with a weight of fifty-one kilograms (BMI: 17.8). Pitting edema of both lower extremities to the proximal shin with hyperpigmentation was noted. As observed on the initial CT scan, there was diffuse lymphadenopathy and right epitrochlear lymphadenopathy in particular was noted. Jugular venous distension was noted to 8 cm above the sternal angle with a positive Kussmaul’s sign on inspiration. The patient had a 3/6 systolic ejection murder without a pericardial knock. There was no oculomasticatory myorhythmia or supranuculear vertical gaze palsy observed.
Transthoracic echocardiogram imaging was reviewed from 2014 to the 2016 (Figs. 1, 2, Additional files 1 and 2). In 2014 (Figs. 1a, 2a and Additional file 1), subtle tethering of the mitral valve was noted with thickening and cord calcification. The posterior leaflet had reduced excursion and the mitral valve apparatus was apically displaced. There was the observation of subtle diastolic doming over the anterior mitral leaflet. Progressive echocardiogram findings in 2016 (Figs. 1b, 2b and Additional file 2) showed the anterior mitral valve to be thickened with reduced excursion, the posterior leaflet to be fixed and cords with shortening. Overall, this was in keeping with pseudoprolapse. Over the aortic valve, there was systolic doming of the right coronary cusp and calcification from the commissural aspect of the aortic valve with sparing of the base. Notably, there was the presence septal shuttering in early diastole with early inspiratory septal bounce/shift, indicative of abnormal heart and lung interaction. Overall, this was suggestive of early constrictive physiology.
A repeat transthoracic echocardiogram on admission showed numerous interval changes including; a reduction in left ventricle systolic function (ejection fraction of 48%), severe mitral regurgitation, moderate tricuspid regurgitation, moderate aortic regurgitation and worsening pulmonary hypertension (RSVP 78 mmHg). Calcific aortic valve changes were noted that were felt to be post-inflammatory as opposed to degenerative changes. The mitral valve had an unusual appearance suggestive of prior valvulitis, in particular rheumatic in nature. The pericardium was thickened with features of exaggerated heart and lung interactions, consistent with constrictive physiology. Based on these findings, pericardial stripping and valvular surgery were proposed.
Perioperative findings consisted of thick pericardium and densely adherent to the surrounding anatomy. The mitral valve was grossly abnormal with fibrosis, in keeping with a rheumatic type process and was subsequently replaced with a bioprosthetic valve. The tricuspid valve had thickened leaflets with slightly thickened papillary muscle and was repaired with a ring annuloplasty. The thickened aortic valve was addressed with primary repair.
The above constellation of symptoms, in the context with prior work-up as unremarkable, lent to a strong clinical suspicion of an atypical presentation of Whipple’s disease. Two days post-op, duodenal biopsies were obtained (Fig. 3a, b), and surprisingly were not consistent with Whipple’s disease. On the request of the clinician, the cardiac valves and pericardium pathology specimens were examined for PAS staining and PCR. The cardiac specimens demonstrated numerous foamy macrophages filled with PAS positive material compatible with Whipple’s disease (Fig. 4). Tropheryma whipplei was identified by direct 16S rDNA PCR on the mitral valve with > 99% sequence match. The pathological changes were consistent with active endocarditis, myocarditis, and pericarditis, caused by T. whipplei. The patient started treatment with IV Penicillin G for 14 days and subsequently maintained regimen of oral sulfamethoxazole-trimethoprim for long-term treatment. Six months following diagnosis, the patient has had no complications and is clinically improving.

Discussion and conclusions

The diagnosis of T. whipplei valvular involvement is elusive as there is the absence of clear diagnostic criteria. Often the diagnosis hinges on 16S rDNA PCR following surgical removal of valvular tissue coinciding with high clinical suspicion from physician vigilance. Currently, limited serologic assays only can distinguish between classic Whipple disease and asymptomatic gastrointestinal carriers.
The diagnostic criterion for Whipple’s disease includes two of three tests to be positive from PAS staining, PCR or immunohistochemistry [8]. The gold standard tissue is considered to be histology from small bowel biopsies, which classically present as PAS-positive foamy macrophages within the lamina propria [9]. However, PAS-positive macrophages are not specific and have been observed in patients with intestinal infections (Mycobacterium avium complex, Rhodococcus. sp., Bacillus cereus, Corynebacterium spp., and Histoplasma spp.,), Crohn’s disease, histiocytosis and Waldenstrom’s macroglobulinemia [911].
We also sought to assess the epidemiology of Whipple’s disease in Canada, which previously was unknown. A consortium of data collected from the National Microbiology Laboratory in Canada was done from 2012 to 2016 and highlighted in Table 2. Notably, only 4% of samples were positive from those collected; of which 13.5% were elucidated from the gold standard of duodenal biopsy, with 86.2% of other tissue types being found to be positive for T. whipplei. A limitation of this should be noted in that multiple samples were present from the same patient. However, this highlights the diagnostic utility of other samples apart from the previously denoted ‘gold standard’ of duodenum.
Table 2
Total number of samples submitted for Tropheryma whipplei PCR testing, number of positive samples, and percent positivity from 2012 to 2016 in Canada
Sample type
2012
2013
2014
2015
2016
Totals
No. Samples
No. Pos
% Pos
No. Samples
No. Pos
% Pos
No. Samples
No. Pos
% Pos
No. Samples
No. Pos
% Pos
No. Samples
No. Pos
% Pos
No. Samples
# Pos
% Pos
GI tract*
30
7
23.33
26
2
7.69
32
3
9.38
42
5
11.90
32
5
15.63
162
22
13.58
Cardiac
3
0
0.00
2
0
0.00
3
1
33.33
5
1
20.00
10
1
10.00
23
3
13.04
Lymph node
4
1
25.00
6
1
16.67
3
0
0.00
0
0
0.00
7
0
0.00
20
2
10.00
Brain
2
0
0.00
1
0
0.00
1
0
0.00
2
0
0.00
6
0
0.00
12
0
0.00
Other tissue
9
0
0.00
6
1
16.67
6
0
0.00
8
1
12.50
16
1
6.25
45
3
6.67
Blood
57
0
0.00
85
2
2.35
102
3
2.94
101
2
1.98
104
1
0.96
449
8
1.78
CSF
41
0
0.00
63
2
3.17
54
0
0.00
76
2
2.63
102
0
0.00
336
4
1.19
Other fluid
4
0
0.00
1
0
0.00
0
0
0.00
0
0
0.00
5
0
0.00
10
0
0.00
Total
150
8
5.33
190
8
4.21
201
7
3.48
234
11
4.70
282
8
2.84
1057
42
3.97
# Positive patients**
6
  
6
  
5
  
9
  
8
     
*GI tract includes fresh or paraffin embedded tissue samples from small and large intestine and samples labelled as “gastric”
**Multiple positive sample types may be submitted from the same patient
Our patient presented with heart failure due to pericardial constriction with multiple cardiac valve involvement in the context of a systemic process including cachexia and neurological impairment with reduced cognition. He did not display classical Whipple’s symptoms including gastrointestinal manifestations and had few PAS-positive macrophages within the intestinal wall. Given the current diagnostic guidelines, this may substantially underrepresent the true incidence of Whipple’s disease in the absence of overriding strong clinical suspicion. The accurate clinical evaluation of the patient described in this case is likely multifactorial and may represent improved modern medical care to bridge to surgery, improved current diagnostic imaging and high clinical acumen. PAS staining is not routinely performed on cardiac specimens at our institution. Furthermore, this patient represents the first description in the literature of constrictive pericarditis with pan-valvular findings. Constrictive pericarditis, involving cardiac valvular pathology, in the absence of common etiologies should promote clinical suspicion as a manifestation of Whipple’s disease even in the absence of gastrointestinal manifestations.
This case further highlights as a key example of blood culture-negative endocarditis (BCNE). BCNE are thought to account for 2.5–70% of all cases of endocarditis based upon standard culture-dependent laboratory techniques, with a differential diagnosis including both infectious and non-infectious etiologies (Table 3) [13]. Among culture-negative endocarditis, T. whipplei was found to be the fourth most common cause as demonstrated by both histological and molecular techniques [14]. A recent study from France demonstrated that by adding real-time PCR assays in patients with BNCE, not only did the diagnostic efficiency improve by 24.3%, but detection of atypical organisms including T. whipplei also increased, thus improving diagnostic certainty [15]. In Canada, epidemiological rates of BCNE are currently unknown, but given the prevalence from prior case series from other countries is likely underreported.
Table 3
Differential Diagnosis for Blood Culture Negative Endocarditis by Etiologya
Infectious
Non-Infectious
⦁ Bartonella species.
⦁ Antiphospholipid syndrome
Brucella melitensis
⦁ Atrial myxoma
⦁ Chlamydia species
⦁ Marantic endocarditis
⦁ Corynebacterium species
⦁ Libman-Sachs endocarditis
Coxiella burnetii
⦁ Mural thrombi
⦁ Enterobacteriaceae species
⦁ Lambl’s excrescences
⦁ Fungal species (mostly Candida)
⦁ Cholesterol emboli
⦁ HACEK bacteria
⦁ Vasculitis (Behcet’s)
⦁ Legionella species
⦁ Paradoxical emboli
⦁ Mycoplasma species
⦁ Left atrial thrombi
⦁ Staphylococcus species
 
⦁ Streptococcus species
 
Tropheryma whipplei
 
aModified from Fournier, et al. [12]
Ultimately, as this case highlights, repeated negative blood cultures should prompt the clinician to further evaluate atypical causes of BCNE, including Whipple’s disease. This case further reinforces prior studies in which addition of molecular studies may aid in diagnostic certainty by increasing positive yield. Further research is required in order to optimize medical care and highlighting a likely under-diagnosed disease; both with regards to Whipple’s disease and BCNE.

Supplementary information

Supplementary information accompanies this paper at https://​doi.​org/​10.​1186/​s12872-019-1257-2.

Acknowledgements

We thank directors at provincial public health laboratories and hospitals as well as astute pathologists for their contributions of biomaterials for Whipple’s disease testing, used in the data analysis shown here. Above all, we thank the patient in this manuscript for granting permission to share this case.
Not applicable.
Written informed consent was obtained from the patient for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.

Competing interests

The authors declare that they have no competing interests.
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://​creativecommons.​org/​licenses/​by/​4.​0/​), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://​creativecommons.​org/​publicdomain/​zero/​1.​0/​) applies to the data made available in this article, unless otherwise stated.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Literatur
1.
Zurück zum Zitat Fleming JL, Wiesner RH, Shorter RG. Whipple's disease: clinical, biochemical, and histopathologic features and assessment of treatment in 29 patients. Mayo Clin Proc. 1988;63(6):539–51.CrossRef Fleming JL, Wiesner RH, Shorter RG. Whipple's disease: clinical, biochemical, and histopathologic features and assessment of treatment in 29 patients. Mayo Clin Proc. 1988;63(6):539–51.CrossRef
2.
Zurück zum Zitat Fenollar F, Puechal X, Raoult D. Whipple's disease. N Engl J Med. 2007;356(1):55–66.CrossRef Fenollar F, Puechal X, Raoult D. Whipple's disease. N Engl J Med. 2007;356(1):55–66.CrossRef
3.
Zurück zum Zitat Durand DV, Lecomte C, Cathebras P, Rousset H, Godeau P. Whipple disease. Clinical review of 52 cases. The SNFMI Research Group on Whipple Disease. Societe Nationale Francaise de Medecine Interne. Medicine (Baltimore). 1997;76(3):170–84.CrossRef Durand DV, Lecomte C, Cathebras P, Rousset H, Godeau P. Whipple disease. Clinical review of 52 cases. The SNFMI Research Group on Whipple Disease. Societe Nationale Francaise de Medecine Interne. Medicine (Baltimore). 1997;76(3):170–84.CrossRef
4.
Zurück zum Zitat Fenollar F, Lepidi H, Raoult D. Whipple's endocarditis: review of the literature and comparisons with Q fever, Bartonella infection, and blood culture-positive endocarditis. Clin Infect Dis. 2001;33(8):1309–16.CrossRef Fenollar F, Lepidi H, Raoult D. Whipple's endocarditis: review of the literature and comparisons with Q fever, Bartonella infection, and blood culture-positive endocarditis. Clin Infect Dis. 2001;33(8):1309–16.CrossRef
5.
Zurück zum Zitat Celard M, de Gevigney G, Mosnier S, et al. Polymerase chain reaction analysis for diagnosis of Tropheryma whippelii infective endocarditis in two patients with no previous evidence of Whipple's disease. Clin Infect Dis. 1999;29(5):1348–9.CrossRef Celard M, de Gevigney G, Mosnier S, et al. Polymerase chain reaction analysis for diagnosis of Tropheryma whippelii infective endocarditis in two patients with no previous evidence of Whipple's disease. Clin Infect Dis. 1999;29(5):1348–9.CrossRef
6.
Zurück zum Zitat Naegeli B, Bannwart F, Bertel O. An uncommon cause of recurrent strokes: Tropheryma whippelii endocarditis. Stroke. 2000;31(8):2002–3.CrossRef Naegeli B, Bannwart F, Bertel O. An uncommon cause of recurrent strokes: Tropheryma whippelii endocarditis. Stroke. 2000;31(8):2002–3.CrossRef
7.
Zurück zum Zitat Marth T, Moos V, Muller C, Biagi F, Schneider T. Tropheryma whipplei infection and Whipple's disease. Lancet Infect Dis. 2016;16(3):e13–22.CrossRef Marth T, Moos V, Muller C, Biagi F, Schneider T. Tropheryma whipplei infection and Whipple's disease. Lancet Infect Dis. 2016;16(3):e13–22.CrossRef
8.
Zurück zum Zitat Schneider T, Moos V, Loddenkemper C, Marth T, Fenollar F, Raoult D. Whipple's disease: new aspects of pathogenesis and treatment. Lancet Infect Dis. 2008;8(3):179–90.CrossRef Schneider T, Moos V, Loddenkemper C, Marth T, Fenollar F, Raoult D. Whipple's disease: new aspects of pathogenesis and treatment. Lancet Infect Dis. 2008;8(3):179–90.CrossRef
9.
Zurück zum Zitat Stojan G, Melia MT, Khandhar SJ, Illei P, Baer AN. Constrictive pleuropericarditis: a dominant clinical manifestation in Whipple's disease. BMC Infect Dis. 2013;13:579.CrossRef Stojan G, Melia MT, Khandhar SJ, Illei P, Baer AN. Constrictive pleuropericarditis: a dominant clinical manifestation in Whipple's disease. BMC Infect Dis. 2013;13:579.CrossRef
10.
Zurück zum Zitat Dutly F, Altwegg M. Whipple's disease and "Tropheryma whippelii". Clin Microbiol Rev. 2001;14(3):561–83.CrossRef Dutly F, Altwegg M. Whipple's disease and "Tropheryma whippelii". Clin Microbiol Rev. 2001;14(3):561–83.CrossRef
11.
Zurück zum Zitat Marth T, Raoult D. Whipple's disease. Lancet. 2003;361(9353):239–46.CrossRef Marth T, Raoult D. Whipple's disease. Lancet. 2003;361(9353):239–46.CrossRef
12.
Zurück zum Zitat Fournier PE, Thuny F, Richet H, et al. Comprehensive diagnostic strategy for blood culture-negative endocarditis: a prospective study of 819 new cases. Clin Infect Dis. 2010;51(2):131–40.CrossRef Fournier PE, Thuny F, Richet H, et al. Comprehensive diagnostic strategy for blood culture-negative endocarditis: a prospective study of 819 new cases. Clin Infect Dis. 2010;51(2):131–40.CrossRef
13.
Zurück zum Zitat Brouqui P, Raoult D. Endocarditis due to rare and fastidious bacteria. Clin Microbiol Rev. 2001;14(1):177–207.CrossRef Brouqui P, Raoult D. Endocarditis due to rare and fastidious bacteria. Clin Microbiol Rev. 2001;14(1):177–207.CrossRef
14.
Zurück zum Zitat Geissdorfer W, Moos V, Moter A, et al. High frequency of Tropheryma whipplei in culture-negative endocarditis. J Clin Microbiol. 2012;50(2):216–22.CrossRef Geissdorfer W, Moos V, Moter A, et al. High frequency of Tropheryma whipplei in culture-negative endocarditis. J Clin Microbiol. 2012;50(2):216–22.CrossRef
15.
Zurück zum Zitat Fournier PE, Gouriet F, Casalta JP, et al. Blood culture-negative endocarditis: improving the diagnostic yield using new diagnostic tools. Medicine (Baltimore). 2017;96(47):e8392.CrossRef Fournier PE, Gouriet F, Casalta JP, et al. Blood culture-negative endocarditis: improving the diagnostic yield using new diagnostic tools. Medicine (Baltimore). 2017;96(47):e8392.CrossRef
Metadaten
Titel
Another Whipple’s triad? Pericardial, myocardial and valvular disease in an unusual case presentation from a Canadian perspective
verfasst von
Christina S. Thornton
Yinong Wang
Martin Köebel
Kathryn Bernard
Tamara Burdz
Andrew Maitland
Jose G. Ferraz
Paul L. Beck
Andre Ferland
Publikationsdatum
01.12.2019
Verlag
BioMed Central
Erschienen in
BMC Cardiovascular Disorders / Ausgabe 1/2019
Elektronische ISSN: 1471-2261
DOI
https://doi.org/10.1186/s12872-019-1257-2

Weitere Artikel der Ausgabe 1/2019

BMC Cardiovascular Disorders 1/2019 Zur Ausgabe

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.